825
Views
8
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70

, , &
Pages 1425-1432 | Received 31 Oct 2016, Accepted 04 Jan 2017, Published online: 16 Mar 2017

References

  • Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis 2004; 84:29-44; PMID: 14670344; https://doi.org/10.1016/j.tube.2003.08.003
  • Sinha M, Jain N, Sudevan K. In silico diagnosis of tuberculosis in multiple species using single nucleotide polymorphism as biological marker. Int J Adv Tech Eng Sci 2014; 2:2348-7550.
  • Masters BR. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Eighth Edition (2015). John E. Bennett, Raphael Dolin, Martin J. Blaser (eds.). ISBN: 13-978-1-4557-4801-3, Elsevier Saunders.
  • Migliori GB, Centis R, Lange C, Richardson MDA, Sotgiu G. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Curr Opin Pulm Med 2010; 16:171-9; PMID: 20134324
  • Lazarus J, Olsen M, Ditiu L, Matic S. Tuberculosis–HIV co‐infection: policy and epidemiology in 25 countries in the WHO European region. HIV Med 2008; 9:406-14; PMID: 18410353; https://doi.org/10.1111/j.1468-1293.2008.00567.x
  • Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45; PMID: 7475776; https://doi.org/10.1016/S0140-6736(95)92348-9
  • Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698-702; PMID: 8309034; https://doi.org/10.1001/jama.1994.03510330076038
  • Zheng YQ, Naguib YW, Dong Y, Shi YC, Bou S, Cui Z. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy. Expert Rev Vaccines 2015; 14:1255-75; PMID:26268434
  • Ahsan MJ. Recent advances in the development of vaccines for tuberculosis. Ther Adv Vaccines 2015; 3:66-75; PMID: 26288734; https://doi.org/10.1177/2051013615593891
  • Yang E, Gu J, Wang F, Wang H, Shen H, Chen ZW. Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice. Microb Pathog 2016; 93:1-7; PMID: 26792673; https://doi.org/10.1016/j.micpath.2016.01.006
  • Xu ZZ, Chen X, Hu T, Meng C, Wang XB, Rao Y, Zhang XM, Yin YL, Pan ZM, Jiao XA. Evaluation of immunogenicity and protective efficacy elicited by mycobacterium bovis BCG Overexpressing Ag85A protein against mycobacterium tuberculosis aerosol infection. Front Cell Infect Microbiol 2016; 6:6; PMID: 26913242
  • Li G, Liu G, Song N, Kong C, Huang Q, Su H, Bi A, Luo L, Zhu L, Xu Y, et al. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice. Mol Immunol 2015; 66:346-56; PMID: 25942359; https://doi.org/10.1016/j.molimm.2015.04.003
  • Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, et al. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Appl Microbiol Biotechnol 2015; 99:10587-95; PMID: 26363555; https://doi.org/10.1007/s00253-015-6962-x
  • Yang E, Lu Y, Xu Y, Liang Q, Wang C, Wang H, Shen H. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice. Microb Pathog 2014; 69:53-9; PMID: 24726737; https://doi.org/10.1016/j.micpath.2014.03.011
  • Chen Y-Y, Lin C-W, Huang W-F, Chang J-R, Su I-J, Hsu C-H, et al. Recombinant bacille Calmette–Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. J Microbiol Immunol Infect 2014; S1684-1182(14)00250-3; PMID: 25732698; https://doi.org/10.1016/j.jmii.2014.11.019
  • Pitt JM, Blankley S, McShane H, O'Garra A. Vaccination against tuberculosis: how can we better BCG? Microbial pathogenesis 2013; 58:2-16; PMID: 23257069; https://doi.org/10.1016/j.micpath.2012.12.002
  • Arrazola MP, Serrano A, Lopez-Velez R. Vaccination for international travelers. Enferm Infecc Microbiol Clin 2016; 34(5):315-23; PMID: 26920587; https://doi.org/10.1016/j.eimc.20
  • Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006; 173:1078-90; PMID: 16484674; https://doi.org/10.1164/rccm.200511-1809SO
  • Subramani R, Datta M, Swaminathan S. Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction? Indian J Tuberc 2016; 62(4):226-9; PMID: 26970464; https://doi.org/10.1016/j.ijtb.2015.08.002
  • Hernandez-Pando R, Castanon M, Espitia C, Lopez-Vidal Y. Recombinant BCG vaccine candidates. Curr Mol Med 2007; 7:365-72; PMID: 17584076; https://doi.org/10.2174/156652407780831610
  • Singh V, Srivastava R, Srivastava B. Manipulation of BCG vaccine: a double-edged sword. Eur J Clin Microbiol Infect Dis 2016; 35:535-43; ; https://doi.org/10.1007/s10096-016-2579-y
  • Tang X-L, Zhou Y-X, Wu S-M, Pan Q, Xia B, Zhang X-L. CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents. J Infect 2014; 69:569-80; PMID: 24968239; https://doi.org/10.1016/j.jinf.2014.05.015
  • Guo S, Xue R, Li Y, Wang SM, Ren L, Xu JJ. The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection. Med Hypotheses 2012; 78:389-92; PMID: 22192908; https://doi.org/10.1016/j.mehy.2011.11.022
  • Millán O, Brunet M. Cytokine-based immune monitoring. Clin Biochem 2016; 49(4-5):338; PMID: 26800778; https://doi.org/10.1016/j.clinbiochem.2016.01.004
  • Deng Y, Sun Z, Yang X, Bao L. Improved Immunogenicity of recombinant mycobacterium bovis bacillus calmette‐guérin strains expressing fusion protein Ag85A-ESAT-6 of mycobacterium tuberculosis. Scand J Immunol 2010; 72:332-8; PMID: 20883318; https://doi.org/10.1111/j.1365-3083.2010.02444.x
  • Yang X, Bao L, Deng Y. A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity. Acta Biochim Biophys Sin (Shanghai) 2011; 43:511-8; PMID: 21676888; https://doi.org/10.1093/abbs/gmr045
  • da Costa AC, de Oliveira Costa-Junior A, de Oliveira FM, Nogueira SV, Rosa JD, Resende DP, Kipnis A, Junqueira-Kipnis AP. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis. PLoS One 2014; 9:e112848; PMID: 25398087; https://doi.org/10.1371/journal.pone.0112848
  • Li W, Li M, Deng G, Zhao L, Liu X, Wang Y. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice. Mol Med Rep 2015; 12:3073-80; PMID:25962477
  • Li W, Huang H, Hua W, Ben S, Liu H, Xu B, Xian Q, Tang Z, Shen H. Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice. Vaccine 2012; 30:3223-30; PMID: 22342709; https://doi.org/10.1016/j.vaccine.2012.02.014
  • Dey B, Jain R, Khera A, Rao V, Dhar N, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK. Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs. Vaccine 2009; 28:63-70; PMID: 19835824; https://doi.org/10.1016/j.vaccine.2009.09.121
  • Deng YH, He HY, Zhang FJ. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Scand J Immunol 2013; 78:497-506; PMID: 24283772; https://doi.org/10.1111/sji.12116
  • Tang X, Deng W, Xie J. Novel insights into Mycobacterium antigen Ag85 biology and implications in countermeasures for M. tuberculosis. Crit Rev Eukaryot Gene Expr 2012; 22:179-87
  • Wang J-F, Dai F-Y, Gong X-L, Bao L. Commonly administered bacille Calmette-Guerin strains induce comparable immune response. Int J Clin Exp Med 2015; 8:15834; PMID:26629084
  • Stover CK, Bansal GP, Hanson MS, Burlein J, Palaszynski S, Young J, Koenig S, Young DB, Sadziene A, Barbour AG.. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med 1993; 178:197-209; PMID: 8315378; https://doi.org/10.1084/jem.178.1.197
  • Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991; 59:1558-63; PMID:1900811

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.